A real-world pharmacovigilance study of abaloparatide based on the FDA Adverse Event Reporting System (FAERS)

被引：0
|
作者：
X. Shi
Q. Cheng
Y.-Z. Zhao
S.-P. Zou
M.-H. Sun
机构：
[1] Huazhong University of Science and Technology, Department of Pharmacy, Tongji Hospital, Tongji Medical College
来源：
Osteoporosis International | 2023年 / 34卷
关键词：
Abaloparatide; Adverse events; Data mining; FAERS; Osteoporosis; Pharmacovigilance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2047 / 2058
页数：11
相关论文
共 50 条
  • [1] A real-world pharmacovigilance study of abaloparatide based on the FDA Adverse Event Reporting System (FAERS)
    Shi, X.
    Cheng, Q.
    Zhao, Y. -z.
    Zou, S. -p.
    Sun, M. -h.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2023, 34 (12) : 2047 - 2058
  • [2] A Real-World Pharmacovigilance Study of FDA Adverse Event Reporting System (FAERS) for Mavacamten
    Yukselen, Zeynep
    Raju, Arvind Kumar Venkataramana
    Kumar, Pramukh Arun
    Ujjawal, Aditi
    Dasari, Mahati
    Parajuli, Shreyash
    Nakhla, Michael
    Bansal, Kannu
    Ganatra, Sarju
    Dani, Sourbha S.
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2024,
  • [3] A real-world pharmacovigilance study of polatuzumab vedotin based on the FDA adverse event reporting system (FAERS)
    Liu, Dan
    Mao, Wei
    Hu, Bin
    Li, Xingxing
    Zhao, Quanfeng
    Zhang, Lin
    Hu, Jing
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [4] A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib
    Yanchao Yin
    Yamin Shu
    Junru Zhu
    Feie Li
    Juan Li
    [J]. Scientific Reports, 12
  • [5] A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib
    Guo, Menglin
    Shu, Yamin
    Chen, Guosong
    Li, Juan
    Li, Feie
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [6] A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) database
    Zou, Fan
    Zhu, Chengyu
    Lou, Siyu
    Cui, Zhiwei
    Wang, Dan
    Ou, Yingyong
    Wang, Li
    Chen, Junyou
    Lan, Yuanbo
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [7] A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib
    Yin, Yanchao
    Shu, Yamin
    Zhu, Junru
    Li, Feie
    Li, Juan
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [8] A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for sunitinib
    Zhang, Xusheng
    Ren, Xiuli
    Zhu, Tianyu
    Zheng, Wanjin
    Shen, Chengwu
    Lu, Cuicui
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [9] A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for venetoclax
    Yang, Yang
    Shu, Yamin
    Chen, Guosong
    Yin, Yanchao
    Li, Feie
    Li, Juan
    [J]. PLOS ONE, 2022, 17 (12):
  • [10] A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib
    Menglin Guo
    Yamin Shu
    Guosong Chen
    Juan Li
    Feie Li
    [J]. Scientific Reports, 12
12345